These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 33101546)
1. Construction and Validation of a Robust Cancer Stem Cell-Associated Gene Set-Based Signature to Predict Early Biochemical Recurrence in Prostate Cancer. Liu B; Li X; Li J; Jin H; Jia H; Ge X Dis Markers; 2020; 2020():8860788. PubMed ID: 33101546 [TBL] [Abstract][Full Text] [Related]
2. Gene signatures predict biochemical recurrence-free survival in primary prostate cancer patients after radical therapy. Su Q; Liu Z; Chen C; Gao H; Zhu Y; Wang L; Pan M; Liu J; Yang X; Tian J Cancer Med; 2021 Sep; 10(18):6492-6502. PubMed ID: 34453418 [TBL] [Abstract][Full Text] [Related]
3. A potential panel of four-long noncoding RNA signature in prostate cancer predicts biochemical recurrence-free survival and disease-free survival. Huang TB; Dong CP; Zhou GC; Lu SM; Luan Y; Gu X; Liu L; Ding XF Int Urol Nephrol; 2017 May; 49(5):825-835. PubMed ID: 28188414 [TBL] [Abstract][Full Text] [Related]
4. Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients. Zhao Y; Tao Z; Li L; Zheng J; Chen X BMC Cancer; 2022 Mar; 22(1):239. PubMed ID: 35246070 [TBL] [Abstract][Full Text] [Related]
5. A novel 13 RNA binding proteins (RBPs) signature could predict prostate cancer biochemical recurrence. Xing Q; Liu S; Luan J; Wang Y; Ma L Pathol Res Pract; 2021 Sep; 225():153587. PubMed ID: 34419719 [TBL] [Abstract][Full Text] [Related]
6. Autophagy-related circRNA evaluation reveals hsa_circ_0001747 as a potential favorable prognostic factor for biochemical recurrence in patients with prostate cancer. Zhong C; Wu K; Wang S; Long Z; Yang T; Zhong W; Tan X; Wang Z; Li C; Lu J; Mao X Cell Death Dis; 2021 Jul; 12(8):726. PubMed ID: 34294687 [TBL] [Abstract][Full Text] [Related]
7. Construction of a set of novel and robust gene expression signatures predicting prostate cancer recurrence. Jiang Y; Mei W; Gu Y; Lin X; He L; Zeng H; Wei F; Wan X; Yang H; Major P; Tang D Mol Oncol; 2018 Sep; 12(9):1559-1578. PubMed ID: 30024105 [TBL] [Abstract][Full Text] [Related]
8. Development and Validation of an Individualized Immune Prognostic Signature for Recurrent Prostate Cancer. Jin Y; Wang L; Lou H; Song C; He X; Ding M Comb Chem High Throughput Screen; 2021; 24(1):98-108. PubMed ID: 32593277 [TBL] [Abstract][Full Text] [Related]
9. Identification of seven long noncoding RNAs signature for prediction of biochemical recurrence in prostate cancer. Shao N; Zhu Y; Wan FN; Ye DW Asian J Androl; 2019; 21(6):618-622. PubMed ID: 30860081 [TBL] [Abstract][Full Text] [Related]
10. Identification a novel set of 6 differential expressed genes in prostate cancer that can potentially predict biochemical recurrence after curative surgery. Li F; Ji JP; Xu Y; Liu RL Clin Transl Oncol; 2019 Aug; 21(8):1067-1075. PubMed ID: 30637711 [TBL] [Abstract][Full Text] [Related]
11. Development and validation of novel inflammatory response-related gene signature to predict prostate cancer recurrence and response to immune checkpoint therapy. Luo Y; Liu X; Lin J; Zhong W; Chen Q Math Biosci Eng; 2022 Aug; 19(11):11345-11366. PubMed ID: 36124593 [TBL] [Abstract][Full Text] [Related]
13. Gene expression signature of Gleason score is associated with prostate cancer outcomes in a radical prostatectomy cohort. Jhun MA; Geybels MS; Wright JL; Kolb S; April C; Bibikova M; Ostrander EA; Fan JB; Feng Z; Stanford JL Oncotarget; 2017 Jun; 8(26):43035-43047. PubMed ID: 28496006 [TBL] [Abstract][Full Text] [Related]
14. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis. Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402 [TBL] [Abstract][Full Text] [Related]
15. A qualitative transcriptional signature for predicting the biochemical recurrence risk of prostate cancer patients after radical prostatectomy. Li X; Huang H; Zhang J; Jiang F; Guo Y; Shi Y; Guo Z; Ao L Prostate; 2020 Apr; 80(5):376-387. PubMed ID: 31961962 [TBL] [Abstract][Full Text] [Related]
16. Fifteen-MiRNA-Based Signature Is a Reliable Prognosis-Predicting Tool for Prostate Cancer Patients. Bian Z; Huang X; Chen Y; Meng J; Feng X; Zhang M; Zhang L; Zhou J; Liang C Int J Med Sci; 2021; 18(1):284-294. PubMed ID: 33390797 [TBL] [Abstract][Full Text] [Related]
17. Identification of a Four Cancer Stem Cell-Related Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Adenocarcinoma. Li S; Chen R; Luo W; Lin J; Chen Y; Wang Z; Lin W; Li B; Wang J; Yang J Comb Chem High Throughput Screen; 2022; 25(12):2070-2081. PubMed ID: 35048799 [TBL] [Abstract][Full Text] [Related]
18. A 16-mRNA signature optimizes recurrence-free survival prediction of Stages II and III gastric cancer. Peng K; Chen E; Li W; Cheng X; Yu Y; Cui Y; Li Q; Wang Y; Xu X; Tang C; Gan L; Yu S; Liu T J Cell Physiol; 2020 Jul; 235(7-8):5777-5786. PubMed ID: 32048287 [TBL] [Abstract][Full Text] [Related]
19. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management. Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136 [TBL] [Abstract][Full Text] [Related]
20. Identification and Validation of a Prognostic 5-Protein Signature for Biochemical Recurrence Following Radical Prostatectomy for Prostate Cancer. Lv D; Cao Z; Li W; Zheng H; Wu X; Liu Y; Gu D; Zeng G Front Surg; 2021; 8():665115. PubMed ID: 34136527 [No Abstract] [Full Text] [Related] [Next] [New Search]